For research use only. Not for therapeutic Use.
Lartesertib (M4076) is a potent inhibitor of serine/threonine protein kinase ATM (extracted from patent WO2022058351A1)[1].
| Catalog Number | I043330 |
| CAS Number | 2495096-26-7 |
| Synonyms | 8-(1,3-dimethylpyrazol-4-yl)-1-(3-fluoro-5-methoxypyridin-4-yl)-7-methoxy-3-methylimidazo[4,5-c]quinolin-2-one |
| Molecular Formula | C23H21FN6O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C23H21FN6O3/c1-12-15(11-28(2)27-12)13-6-14-17(7-19(13)32-4)26-9-18-21(14)30(23(31)29(18)3)22-16(24)8-25-10-20(22)33-5/h6-11H,1-5H3 |
| InChIKey | WNEFOSMCGCLLJU-UHFFFAOYSA-N |
| SMILES | CC1=NN(C=C1C2=C(C=C3C(=C2)C4=C(C=N3)N(C(=O)N4C5=C(C=NC=C5OC)F)C)OC)C |
| Reference | [1]. Alessandra AMBRUOSI, et al. Pharmaceutical preparation. WO2022058351A1. |
